Covered recipient · General Payments record
KELLY M TRUMBLE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$746.73
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $487.49 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $126.08 | 1 |
| Acerta Pharma LLC | $81.85 | 2 |
| SANOFI-AVENTIS U.S. LLC | $49.30 | 2 |
| Amgen Inc. | $46.29 | 3 |
| Exact Sciences Corporation | $44.62 | 2 |
| Lilly USA, LLC | $38.31 | 2 |
| ABBVIE INC. | $32.43 | 1 |
| PFIZER INC. | $21.84 | 1 |
| Novo Nordisk AS | $17.79 | 1 |
| GlaxoSmithKline, LLC. | $15.20 | 1 |
| Astellas Pharma US Inc | $13.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.43 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108330550 | CMS |
| Amgen Inc. | $15.09 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402354 | CMS |
| Amgen Inc. | $17.77 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117704680 | CMS |
| Amgen Inc. | $13.43 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402356 | CMS |
| Astellas Pharma US Inc | $13.78 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139506719 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.13 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105807330 | CMS |
| AstraZeneca Pharmaceuticals LP | $67.72 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105467581 | CMS |
| Exact Sciences Corporation | $17.40 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114524649 | CMS |
| Exact Sciences Corporation | $27.22 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114524651 | CMS |
| GlaxoSmithKline, LLC. | $15.20 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116288665 | CMS |
| Lilly USA, LLC | $20.00 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135773600 | CMS |
| Lilly USA, LLC | $18.31 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135760226 | CMS |
| Merck Sharp & Dohme LLC | $126.08 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141622695 | CMS |
| Novo Nordisk Inc | $17.79 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100251742 | CMS |
| PFIZER INC. | $21.84 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130997725 | CMS |
| SANOFI-AVENTIS U.S. LLC | $24.91 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139939255 | CMS |
| SANOFI-AVENTIS U.S. LLC | $24.39 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139939341 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.